BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/21/2025 2:05:35 PM | Browse: 0 | Download: 0
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Minireviews |
Article Title |
Inclusion criteria for liver transplantation in patients with colorectal liver metastases: How to make the best selection?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Maja Cigrovski Berkovic, Anna Mrzljak, Fabio Melandro and Quirino Lai |
Funding Agency and Grant Number |
|
Corresponding Author |
Maja Cigrovski Berkovic, Associate Professor, MD, PhD, Department for Sport and Exercise Medicine, University of Zagreb Faculty of Kinesiology, Horvacanski zavoj 15, Zagreb 10000, Croatia. maja.cigrovskiberkovic@gmail.com |
Key Words |
Colorectal carcinoma; Liver metastases; Liver transplantation; Donor characteristics; Recipient characteristics; Outcomes |
Core Tip |
Colorectal cancer liver metastases (CRLM) strongly impact patients’ survival despite available chemotherapy, surgical removal of liver metastases, and locoregional treatment alone or in combination with systemic chemotherapy. In the last few decades, liver transplantation (LT) in a selected patient population has significantly improved survival, nearing 83% during a 5-year follow-up. The selection of patients with CRLM for LT represents a significant challenge, requiring a balance between oncological outcomes and organ scarcity. Stringent criteria for eligible patient selection are key to long-term patient survival and can be summarized into those related to tumor biology and oncological factors, patient and donor characteristics, and previous response to therapy. Until more generalizable data are available, we explore and compare the inclusion and exclusion criteria used in various studies registered on ClinicalTrials.gov, highlighting their similarities, differences, and implications. |
Citation |
Cigrovski Berkovic M, Mrzljak A, Melandro F, Lai Q. Inclusion criteria for liver transplantation in patients with colorectal liver metastases: How to make the best selection? World J Clin Oncol 2025; In press |
 |
Received |
|
2025-03-03 02:59 |
 |
Peer-Review Started |
|
2025-03-03 02:59 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-14 06:15 |
 |
Revised |
|
2025-04-03 12:00 |
 |
Second Decision |
|
2025-05-21 02:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-21 14:05 |
 |
Articles in Press |
|
2025-05-21 14:05 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345